Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

PARD $0.19 0.0700 +58.33%
ARIA $9.89 2.9100 +41.69%
EPZM $20.10 2.6000 +14.86%
SNSS $1.21 0.1500 +14.15%
BLRX $1.53 0.1700 +12.50%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CCXI $6.50 -0.3900 -5.66%
NWBO $8.11 -0.1900 -2.29%
PGNX $7.67 -0.1600 -2.04%
VBLT $5.31 -0.1100 -2.03%
PFE $32.66 -0.6000 -1.80%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

FDA: 5,000 Orlando Patients May Have Had Bad Mammograms at Imaging Center

(Orlando Sentinel) Aug 26, 2015 - The Food and Drug Administration has issued an alert for patients who have had mammograms at the Boston Diagnostic Imaging facility on Orange Avenue on or after May 13, 2013, because there could be potential problems with the quality of their mammograms.
read article 

'Just Mayo' Not Actually Mayo, Says FDA

(CNNMoney) Aug 25, 2015 - The FDA has issued a warning to Hampton Creek Foods for its product "Just Mayo." The food startup cannot call its vegan, egg-free condiment "mayo" when it doesn't contain the key ingredient, said the FDA in a letter from August 12 that was made public Tuesday.
read article 

UK Launch for Lilly, Boehringer's Biosimilar Insulin

(PharmaTimes [UK]) Aug 26, 2015 - Diabetes patients across the UK can now access Eli Lilly and Boehringer Ingelheim’s biosimilar insulin glargine Abasaglar (previously Abasria) following its launch across the country this week.
read article 

Novo to Begin Phase III Trial of Oral Diabetes Treatment

(Reuters) Aug 26, 2015 - Novo Nordisk said on Wednesday it would begin a Phase III trial of its treatment for diabetes that could be taken orally rather than by injection after "encouraging" results in previous trials.
read article 

FDA Grants Priority Review to Sarepta Drug Candidate

(Wall Street Journal) Aug 25, 2015 - U.S. health regulators granted priority review status for Sarepta Therapeutics Inc.’s treatment of a rare genetic disorder.
read article (paid subscription required) 

Biosimilars Council Urges CMS to Wait on Part B Reimbursement for Interchangeable Biologic Products

(GPhA) Aug 25, 2015 - The Biosimilars Council, a division of the Generic Pharmaceutical Association (GPhA), continues to raise concerns about the proposed rule issued by the Centers for Medicare and Medicaid Services (CMS) regarding biosimilars' reimbursement under Medicare Part B.
read press release 

White House Is Pressed to Help Widen Access to Hepatitis C Drugs via Medicaid

(New York Times) Aug 25, 2015 - Federal and state Medicaid officials should widen access to prescription drugs that could cure tens of thousands of people with hepatitis C, including medications that can cost up to $1,000 a pill, health care experts have told the White House.
read article 

5 Ways to Build Your Cancer Support Network

(Huffington Post) Aug 25, 2015 - A strong social support system is vital for both your mental and physical health following cancer. Your social support system will provide guidance, advice, and assistance; offer shoulders to cry on; and help relieve stress.
read article 

NCCN Publishes New Patient Education Resources for Kidney Cancer

(NCCN) Aug 25, 2015 - NCCN has published the NCCN Guidelines for Patients® and NCCN Quick Guide™ for Kidney Cancer, the newest addition to the library of NCCN Guidelines for Patients.
read press release 

St. James Hires Oncologist -- and Loses an Oncologist in Protest

(Montana Standard [Butte, MT] Aug 26, 2015 - St. James Hospital, moving to address the declining percentage of cancer patients from the area going to the hospital for care, has hired a new oncologist with a blemish on his record.
read article 

Former Cancer Agency Official Found Not Guilty

(Texas Tribune) Aug 25, 2015 - A former high-ranking official with the Cancer Prevention and Research Institute of Texas — accused of deceiving colleagues to secure an $11 million grant for a biotechnology firm — was found not guilty Tuesday by a 12-member jury in Austin.
read article 

Illinois Man Denies Cancer Drug Smuggling Conspiracy Charge

(ABC News/Associated Press) Aug 25, 2015 - An Illinois man pleaded not guilty Tuesday to conspiring with an online Canadian pharmacy to smuggle mislabeled, unapproved and, in two cases, counterfeit prescription drugs into the U.S. to sell to doctors.
read article 

Biotech Selloff Has No Effect on Cellectis Advances: CEO

(TheStreet) Aug 26, 2015 - The selloff in immunotherapy stocks is purely market-based and does not reflect the stunning advances in the cancer fighting space, said Dr. Andre Choulika, CEO of Cellectis.
read article 

Sequenom Enters Collaboration With University of California, San Diego (UCSD) Moores Cancer Center With Novel Liquid Biopsy Assay

(Sequenom) Aug 25, 2015 - Sequenom, Inc. today announced that it has entered into a clinical research collaboration with the University of California, San Diego Moores Cancer Center.
read corporate press release 

Syndax Enters Clinical Trial Collaboration in Cancer Immunotherapy Combining Entinostat and Atezolizumab

(Yahoo! Finance) Aug 26, 2015 - Phase 1b/2 trial with Genentech will assess the safety and efficacy of combining these investigational therapies for the treatment of triple-negative breast cancer.
read article 

Immatics and MD Anderson Announce Launch of Immatics US, Inc., to Develop Multiple T-cell and TCR-based Adoptive Cellular Therapies

(MD Anderson) Aug 26, 2015 - Immatics Biotechnologies GmbH and The University of Texas MD Anderson Cancer Center announced today the launch of Immatics US, Inc., a new company aiming at becoming a global leader in adoptive cellular therapies (ACT) for the treatment of a range of tumor types.
read press release 

FDA and EMA Accept Regulatory Applications for Boehringer Ingelheim's Gilotrif® (afatinib) for Treatment of Advanced Squamous Cell Carcinoma of the Lung

(Boehringer Ingelheim) Aug 25, 2015 - Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
read corporate press release 

Alliance Foundation Trials and Austrian Breast & Colorectal Cancer Study Group Open Largest Global Phase 3 Trial of Targeted Therapy, IBRANCE® (palbociclib), for Patients with Hormone Receptor–Positive Early Breast Cancer

(MarketWatch) Aug 26, 2015 - The Alliance Foundation Trials, LLC (AFT), the Austrian Breast & Colorectal Cancer Study Group (ABCSG) and Pfizer Inc. today announced the launch of the Palbociclib Collaborative Adjuvant Study, or PALLAS.
read article 

Ibandronate Similar to Radiation for Prostate Cancer Bone Pain

(Medscape Medical News/Reuters Health) Aug 25, 2015 - When radiation for metastatic prostate cancer bone pain is not available, ibandronate may be another option, UK researchers suggest.
read article (free registration required) 

Gender Influences Survival After Pediatric Brain Tumor Removal

(Cornell University/Cornell Chronicle) Aug 25, 2015 - It’s an unexpected discovery: All else being equal, girls whose rare and deadly brain tumors are fully removed live almost six years longer than boys with the same condition.
read article 

Circulating Tumor Cell Assays May Play Role in Managing Bladder CA

(Monthly Prescribing Reference/HealthDay News) Aug 25, 2015 - Circulating tumor cell assays may have a role in the management of bladder cancer, according to a study published in the September issue of The Journal of Urology.
read article 

New Study Provides Links Between Inflammation, Spread Of Colon Cancer

(ASU News) Aug 25, 2015 - A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
read article 

Longer Colonoscopies Linked To Lower Cancer Rate

(U.S. Dept. of Veterans Affairs/Research Currents) Aug 20, 2015 - If a colonoscopy seems like the type of thing you'd like to get done with quickly, think again. Research by a Veterans Affairs team has confirmed that longer-lasting colonoscopies are associated with lower cancer rates.
read article 

Promising Target for New Drugs Found in Pancreatic Cancer Cells

(University of Houston) Aug 24, 2015 - UH researchers aiming to defeat one of deadliest cancers by targeting liver X receptors.
read article 

Focused Electrical Blasts Significantly Increase Survival for Patients with Pancreatic Cancer

(University of Louisville) Aug 25, 2015 - Use of irreversible electroporation (IRE) doubles the survival time for patients with locally advanced pancreatic cancer say researchers at the University of Louisville in a paper in the September edition of the Annals of Surgery.
read press release